TrialsgrambetaRCTs are beautiful

COURAGE

2007

Clinical Outcomes Utilising Revascularisation and Aggressive Drug Evaluation

In 2,287 patients with stable coronary artery disease, PCI added to optimal medical therapy did not reduce death or non-fatal MI compared with optimal medical therapy alone.

Result

Efficacy: Death or non-fatal MIHR 1.05

Below 1 favours PCI added to optimal medical therapy, above 1 favours optimal medical therapy alone.

Event rates
Absolute difference
0.5 points

The absolute difference is derived from the event rates.

Also reported: Angina relief favoured PCI early but converged by 5 yr.

Original publication
Subtopic
Revascularisation
Design
RCT, median 4.6 yr
Relevance
Supporting: context rather than must-know.
Source
Boden WE, et al. N Engl J Med. 2007;356(15):1503-1516.doi 10.1056/NEJMoa070829

Discussion & critique

Bare-metal stent era, ~ 30 % crossover from medical arm to PCI. Did not include FFR guidance. Still the conceptual anchor for medical-therapy-first.

Discussed in podcasts